Skip to content
WeighLab
Menu

Head-to-head · Cost-Efficiency Index

Medro vs VitaFusions IV

Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.

Better valueGrade C · #253

Medro

Shoppers who will commit to a longer plan to unlock Medro's lowest published tier.

Visit Medro
VS
Grade C · #259

VitaFusions IV

Cost-first shoppers who want texas-area shoppers who want a flat, no-contract monthly GLP-1 price alongside an existing IV-therapy relationship.

Visit VitaFusions IV

The verdict

Too close to callGrade C vs C

Medro and VitaFusions IV tie on the Cost-Efficiency Index at 60/100, so neither wins outright on the numbers. For most shoppers we'd start with Medro (ranked #253, a hair above #259) — Shoppers who will commit to a longer plan to unlock Medro's lowest published tier. But VitaFusions IV is a genuine coin-flip alternative here.

Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Medro.

Factor by factor

Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.

Normalized Cost/Month

47
59

Price Transparency

54
94

Nationwide Access

86
24

Formulation Options

79
66

Clinical Oversight

63
74

Contract Flexibility

33
37

Pricing, coverage & formulary

The disclosed facts behind the scores. Lower price wins its row (teal).

SpecMedroVitaFusions IV
Cost-Efficiency Index60/10060/100
Semaglutide / mo$199/mo (compounded)$149/mo (all doses, contract term, plus a separate fee, compounded)
Tirzepatide / mo$299/mo (compounded)$189/mo (all doses, contract term, compounded)
Semaglutide / yr (modeled)$2,388$1,788
Tirzepatide / yr (modeled)$3,588$2,268
CoverageAll 50 statesCoverage not published
Oral / sublingualNoNo
Brand-name accessYesCompounded only
Rank here#253#259

Medro

60/100

Where the value is

  • Live pricing tiers for both semaglutide and tirzepatide are transparent and fully disclosed (month-to-month through 12-month) without needing to enter the intake flow
  • LegitScript-certified (seal #50716646, verified against legitscript.com) and available in all 50 states
  • Named clinical partner (Arora Health & Aesthetics, LLC — Dr. Sean Arora, NPI 1841729449, Seattle, WA) and named compounding pharmacy (The Pharmacy Hub, Miami, FL) — both real, both verifiable, though neither is surfaced in the site's marketing copy

The tradeoffs

  • The lowest advertised rate ($149 semaglutide / $224 tirzepatide) requires a full 12-month prepaid commitment; the no-commitment month-to-month rate is 33% higher ($199/$299)
  • No mg dose is disclosed for any pricing tier — the plans are priced by commitment length only, so it's unclear what dose a given monthly price actually delivers
Visit Medro

Full Medro review →

VitaFusions IV

60/100

Where the value is

  • Flat, dose-independent monthly price on both drugs — 'the price you start with is the price you keep,' explicitly no increases as dose is titrated up
  • Named dispensing pharmacy (New Solutions Functional Wellness Pharmacy, with a listed phone number)
  • No memberships, contracts, or autodrafts — genuinely pay-as-you-go per the site's own language

The tradeoffs

  • No evidence of service outside Texas — the site speaks only of Dallas and 'across Texas,' with no states-served list
  • No named prescriber or medical director anywhere on the site
Visit VitaFusions IV

Full VitaFusions IV review →

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.

Keep comparing

← All head-to-head comparisons